Drugs / Xuefu-Zhuyu Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04218487 | Dec 2019 → Dec 2023 | coronary artery disorder, endometriosis, headache disorder, insomnia | Zhong Wang | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xuefu-Zhuyu Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04218487 ↗ |
| Known as | XFZY | “"Xuefu-Zhuyu capsule" (XFZY) is made from a classic Fangji "Xuefu-Zhuyu Decoction" in an ancient Chinese medical book "Yi Lin Gai Cuo" by Chinese physician Wang Qingren, which...” NCT04218487 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “XFZY concludes 11 kinds of Chinese herbs” NCT04218487 ↗ |